GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 805 filers reported holding GLAXOSMITHKLINE PLC in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,165,000 | -7.1% | 26,768 | -7.0% | 0.14% | +14.9% |
| Q1 2022 | $1,254,000 | -21.7% | 28,797 | -20.7% | 0.12% | -20.4% |
| Q4 2021 | $1,601,000 | +274.9% | 36,298 | +402.5% | 0.15% | +245.5% |
| Q2 2021 | $427,000 | -75.5% | 7,223 | -85.2% | 0.04% | -75.6% |
| Q1 2021 | $1,744,000 | +66.6% | 48,856 | +71.8% | 0.18% | -39.6% |
| Q4 2020 | $1,047,000 | +45.4% | 28,445 | +48.6% | 0.30% | +201.0% |
| Q3 2020 | $720,000 | +129.3% | 19,136 | +148.8% | 0.10% | +125.0% |
| Q2 2020 | $314,000 | +13.8% | 7,691 | +5.5% | 0.04% | -2.2% |
| Q1 2020 | $276,000 | -19.1% | 7,288 | +0.3% | 0.04% | -6.2% |
| Q4 2019 | $341,000 | +15.6% | 7,264 | +5.0% | 0.05% | +9.1% |
| Q3 2019 | $295,000 | +15.2% | 6,916 | +8.1% | 0.04% | +12.8% |
| Q2 2019 | $256,000 | -14.4% | 6,395 | -10.6% | 0.04% | -20.4% |
| Q1 2019 | $299,000 | +41.7% | 7,152 | +29.8% | 0.05% | +25.6% |
| Q4 2018 | $211,000 | +3.9% | 5,512 | +5.9% | 0.04% | -23.5% |
| Q1 2018 | $203,000 | – | 5,207 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |